Easy To Use Patents Search & Patent Lawyer Directory
At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.
Searching:
Search by keyword, patent number, inventor, assignee, city or state:
| Patent # | Description |
|---|---|
| US-9,782,388 |
BIS-cyclic guanidine compound compositions, methods of use and treatment
thereof The present disclosure provides compositions including a bis-cyclic guanidine compound, pharmaceutical compositions including a bis-cyclic guanidine compound,... |
| US-9,782,387 |
Compositions and methods for treating hematological malignancies A compound represented by Formula I is provided for use in the treatment of a hematological malignancy in a subject in need thereof. Also provided are... |
| US-9,782,386 |
CDC7 kinase inhibitors and uses thereof The invention provides compounds, methods, pharmaceutical compositions, and kits for the treatment of proliferative disorders such as cancer. In one aspect, the... |
| US-9,782,385 |
Artificial tears solution combination An artificial tears solution combination is composed mainly of an anti-inflammation and anti-oxidation material, a liquid viscosity-enhancing agent, and an... |
| US-9,782,384 |
Suspension compositions of physiologically active phenolic compounds and
methods of making and using the same The present invention is directed to compositions comprising physiologically active phenolic compounds and methods for making and using the same. In particular... |
| US-9,782,383 |
Prophylactic and therapeutic agent for attention-deficit/hyperactivity
disorder It is already known that 1-(benzofuran-2-yl)-2-propylaminopentane or a pharmacologically acceptable acid addition salt thereof exhibits an excellent effect as... |
| US-9,782,382 |
TOFA analogs useful in treating dermatological disorders or conditions This invention is directed to analogs of 5-(tetradecyloxy)-2-furancarboxylic acid (TOFA) and their use in the treatment of dermatological disorders or... |
| US-9,782,381 |
Molecular targets for healing or treating wounds Molecular target for healing or treating wounds and, in particular chronic, human wounds, are described. The molecular target is PTPRK, or a protein 50%... |
| US-9,782,380 |
Method for treating ovarian cancer and/or Hodgkin lymphomia with a
gold(III) complex A method for treating cancer and gold(III) complexes with diaminocyclohexane ligand as anticancer agents. Also described are a pharmaceutical composition... |
| US-9,782,379 |
Use of protectin DX for the stimulation of muscular IL-6 secretion The present invention provides a method for the stimulation of secretion or expression of muscular IL-6 in a subject with the administration of Protectin DX... |
| US-9,782,378 |
Microorganisms that extracellularly secrete lipid particles encapsulating
lipids There are provided microorganisms having a property of producing a lipid containing unsaturated fatty acids as constituent fatty acids and extracellularly... |
| US-9,782,377 |
Composition for normalization of infradian rhythm A composition having a normalizing action for infradian rhythm and/or a synchronization promoting action for circadian rhythm (biological clock) containing... |
| US-9,782,376 |
Levothyroxine liquid formulations The present invention is directed to a liquid formulation comprising levothyroxine or a pharmaceutically acceptable salt thereof. The formulation of the present... |
| US-9,782,375 |
Methods and compositions for improving microvascular function, suppressing
cyclooxygenase activity, reducing... Methods of suppressing cyclooxygenase activity or reducing platelet aggregation of a mammal in need thereof by administering to a mammal in need thereof an... |
| US-9,782,374 |
All-natural enteric soft capsules Described herein are soft capsules and enteric soft capsules comprising cationic Type A gelatin and acid insoluble enteric polymers. In particular, the... |
| US-9,782,373 |
Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver
disorders The invention provides 1,3-diphenylprop-2-en-1-one derivatives and pharmaceutical compositions comprising the same for treating liver disorders, in particular... |
| US-9,782,372 |
Pharmaceutical composition for the treatment of fungal infections There is provided pharmaceutical compositions suitable for topical application to the nail for the treatment of nail diseases such as onychomycosis, comprising... |
| US-9,782,371 |
Composition for promoting remyelination in nerve cells comprising
2,5-dihydroxybenzenesulfonic acid and use thereof A method of preventing or treating a disease associated with demyelination of a nerve cell in a mammal, a method of promoting remyelination or suppressing... |
| US-9,782,370 |
Pharmaceutical compositions of benzenesulfonamide derivatives for
treatment of adenoid cystic carcinoma Provided is a method for treating adenoid cystic carcinoma by using a pharmaceutical composition including benzenesulfonamide derivatives and pharmaceutically... |
| US-9,782,369 |
Method of treating pain using an acetaminophen dimer ether-linked through
phenolic hydroxyl groups Provided herein is a method for treating pain in a subject without risking hepatotoxicity by administering a pharmaceutical composition containing an... |
| US-9,782,368 |
Use of N,N-bis-2-mercaptoethyl isophthalamide According to the invention there is provided N,N-bis-2-mercaptoethyl isophthalamide, or a pharmaceutically acceptable salt or derivative thereof, for use in... |
| US-9,782,367 |
Process for obtaining a modafinil-based pharmaceutical composition,
resulting pharmaceutical composition and... The present invention relates to a novel method for obtaining a pharmaceutical composition based on modafinil. This method consists of solubilizing S modafinil... |
| US-9,782,366 |
Drug for killing acid-fast (red) bacillus Disclosed is a drug for killing acid-fast (red) bacillus and use thereof. The drug, using fuchsin as active ingredient, can effectively kill acid-fast bacillus... |
| US-9,782,365 |
Solid ambroxol-containing preparation The present invention relates to solid preparations containing ambroxol which are obtainable by melt extrusion of the mixture consisting of a) 30 to 80% by... |
| US-9,782,364 |
Curcumin-based compositions and methods of use thereof Methods for reducing MSK1 levels in a plurality of cells are disclosed. For example, the methods include providing to the cells a curcumin composition that is... |
| US-9,782,363 |
Anti-virulance compositions and methods A method of reducing the virulence of a bacterium that expresses accessory gene regulator A (AgrA) or an ortholog of AgrA includes administering to the... |
| US-9,782,362 |
Uses of compositions containing a roasted extract and xanthohumol The present invention primarily relates to specific uses of a composition containing a roasted extract and xanthohumol for health-promoting purposes. In... |
| US-9,782,361 |
Anticonvulsant activity of turmeric oil and bisabolene sesquiterpenoids The present invention relates to the anti-convulsant activity of turmeric oil and its volatile bisabolene sesquiterpenoids ar- turmerone, .alpha.-turmerone,... |
| US-9,782,360 |
Fluorinated CBD compounds, compositions and uses thereof The present invention relates to fluorine substituted CBD compounds, compositions thereof and uses thereof for the preparation of medicaments. |
| US-9,782,359 |
Opioid composition for treating skin lesions The present invention relates to a composition, comprising (i) a matrix made of polymeric nanofibers, and (ii) an opioid agonist within the matrix. |
| US-9,782,358 |
Substance-containing vesicle, and production method therefor Provided is a monodisperse agglomerate of a substance-containing vesicle filled with a substance at a concentration higher than conventionally possible. A mixed... |
| US-9,782,357 |
RNAi molecule delivery platform based on single-siRNA and shRNA
nanocapsules Novel siRNA and shRNA nanocapsules and delivery methods are disclosed herein. These siRNA and shRNA nanocapsules and delivery methods are highly robust and... |
| US-9,782,356 |
Capsule shells comprising an esterified cellulose ether A polymeric capsule shell of high quality is prepared from an aqueous composition which comprises (A) at least one esterified cellulose ether comprising... |
| US-9,782,355 |
Continuous method for producing nanoparticles and nanoparticles obtained
by means of said method The invention relates to a continuous method for producing inorganic or organic nanoparticles having multiple nuclei functionalised with proteins, using a... |
| US-9,782,354 |
Enteric active substance delivery An oral enteric delivery system includes an outer shell assembled from multiple solid shell segments joined together by a binder. The binder does not dissolve... |
| US-9,782,353 |
Film coated tablet containing choline alfoscerate and process for
preparing the same The present invention provides a film coated tablet comprising a first film coating layer comprising hydroxypropyl methylcellulose and a second film coating... |
| US-9,782,352 |
Pharmaceutical composition comprising Krebs cycle precursor salt, in
particular citrate salt, and use thereof... A solid oral pharmaceutical composition in the form of a tablet consisting of a core including a Krebs cycle precursor salt as active ingredient, and of a... |
| US-9,782,351 |
Immunomodulation using spores and pollen grains The present invention includes compositions, methods of making and using the compositions for modulating the immune response in a subject by providing a vaccine... |
| US-9,782,350 |
Coated devices and methods for coating The present invention relates in a first aspect to a method of coating surfaces of substrates with a lattice-like structure. In particular, the present... |
| US-9,782,349 |
Liposomes useful for drug delivery The present invention provides liposome compositions containing substituted ammonium and/or polyanion, and optionally with a desired therapeutic or imaging... |
| US-9,782,348 |
Ingestible formulations for transient, noninvasive reduction of gastric
volume Provided are ingestible polymeric formulations and oral dosage forms for the reduction of gastric volume in the treatment of overweight and obese patients. The... |
| US-9,782,347 |
Topical corticosteroids for the treatment of inflammatory diseases of the
gastrointestinal tract Provided herein are methods for preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the... |
| US-9,782,346 |
Biodegradable ocular implant Provided is a biodegradable ocular implant for sustained drug delivery, including a first layer comprising a first biodegradable polymer, wherein the first... |
| US-9,782,345 |
Ocular composition and method An ocular composition can include a polymer matrix and an antibiotic dispersed in the polymer matrix. The polymer matrix can contain a thiolated hyaluronic acid... |
| US-9,782,344 |
Stable glucagon peptide formulations There is provided glucagon formulations suitable for preparing coatings on microneedle patches for the transdermal delivery of glucagon. The coated patches may... |
| US-9,782,343 |
Method and system for synthesizing nanocarrier based long acting drug
delivery system for morphine The embodiments herein provide a nano-carrier system for delivering a long-acting injectable drug of morphine and a method of synthesising the same. The... |
| US-9,782,342 |
Composite magnetic nanoparticle drug delivery system A composite magnetic nanoparticle drug delivery system provides targeted controlled release chemotherapies for cancerous tumors and inflammatory diseases. The... |
| US-9,782,341 |
Delivery of hydrophobic bioactive agents A composition for delivery of a hydrophobic bioactive agent is provided that provides for a partially solubilized storage solution that upon exposure to the air... |
| US-9,782,340 |
Hair bleaching or hair dye cosmetics A cosmetic product for hair bleaching or hair dyeing comprises a first agent containing an alkali agent, a second agent containing hydrogen peroxide, and a... |
| US-9,782,339 |
Oral care compositions Described herein are oral care compositions comprising a crosslinked polyvinylpyrrolidone complexed with hydrogen peroxide, together with particular co-polymers... |
File A Patent Application
- Protect your idea -- Don't let someone else file first. Learn more.
- 3 Easy Steps -- Complete Form, application Review, and File. See our process.
- Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.